Cargando…
Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
This 9-month randomised, parallel, double-blind, single-centre, placebo-controlled study (PROBE, ISRCTN18030882) assessed the impact of probiotic supplementation on bodyweight. Seventy overweight Bulgarian participants aged 45–65 years with BMI 25–29.9 kg/m(2) received a daily dose of the Lab4P prob...
Autores principales: | Michael, D. R., Davies, T. S., Jack, A. A., Masetti, G., Marchesi, J. R., Wang, D., Mullish, B. H., Plummer, S. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788077/ https://www.ncbi.nlm.nih.gov/pubmed/33408364 http://dx.doi.org/10.1038/s41598-020-78285-3 |
Ejemplares similares
-
The Impact of Lab4 Probiotic Supplementation in a 90-Day Study in Wistar Rats
por: Webberley, Thomas S., et al.
Publicado: (2021) -
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?
por: Mullish, Benjamin H., et al.
Publicado: (2021) -
Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
por: O’Morain, Victoria L., et al.
Publicado: (2023) -
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being
por: Michael, D. R., et al.
Publicado: (2020) -
The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice
por: Michael, D. R., et al.
Publicado: (2017)